Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Semaglutide is an increasingly popular weight loss medication helping patients lose significant quantities of weight and minimizing the health risks associated with obesity
Understanding Semaglutide Semaglutide is a game-changing medication in the treatment of type-2 diabetes and weight management
A meta-analysis of 82 studies involving over 213,000 survivors found that women with obesity had a 41% higher risk of dying from any cause compared with women at a healthy weight
At Pure Medical Spa , we understand that weight loss needs to be realistic and sustainable
Xie et al., 2004)
This GLP-1 Receptor Agonist for weight loss exclusion existed for Pennsylvania ACA Small Group & Individual (and Small Group Grand-mothered in Northeastern PA) already Weight loss medications, including GLP-1s FDA approved for weight loss , is automatically excluded from coverage beginning with December 1, 2024 plan renewal dates and upon renewals occurring thereafter for the following newly impacted PA segments: PA Fully Insured Large Group ( unless specifically meeting grandfathered status requirements ) PA Fully Insured Small Group Grand-mothered in Western PA and Central PA Coverage of GLP-1s FDA approved for diabetes will not be impacted, although some Authorizations or Medical Management may apply
